TCM as an Adjuvant Treatment in Breast Cancer Patients

Chinese herbs can alleviates the side effects caused by conventional treatment in breast cancer patients and affects the syndrome element differentiation by altering the specific set of proteomes at specific time point of treatment.

Trial Details

NCT ID
NCT04843865
Phase
NA
Sponsor
Universiti Tunku Abdul Rahman
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Chinese Herbs
Locations (sample)
  • Bukit Bintang, Kuala Lumpur, Malaysia|3.14657,101.71023

Key Eligibility Criteria

  • Postmenopausal women as determined by cessation of menses for at least 1 year or FSH\>20 mIU/mL
  • Histology confirmed stage 2 to 3 hormone-receptor positive breast cancer patient
  • Currently taking letrozole for at least 1 month
  • Reported ongoing musculoskeletal pain or stiffness, which started or worsened after initiation of letrozole

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →